Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,445 USD | -1,09% | -11,09% | -20,77% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 8,66 mln. 8,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -4 mln. -3,75 mln. | Nettowinst (verlies) 2025 * | -13 mln. -12,19 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,65
x | K/w-verhouding 2025 * |
-1,5
x | Werknemers | 4 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,29% |
Recentste transcriptie over Virios Therapeutics, Inc.
1 dag | -1,09% | ||
1 week | -11,09% | ||
Lopende maand | -4,91% | ||
1 maand | +28,70% | ||
3 maanden | -43,82% | ||
6 maanden | -26,04% | ||
Lopend jaar | -20,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01-01-18 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 01-04-20 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 21-12-20 |
Richard Whitley
BRD | Director/Board Member | 78 | 21-12-20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 0,4556 | +1,26% | 13 228 |
18-04-24 | 0,4499 | -0,22% | 62 794 |
17-04-24 | 0,4509 | -0,24% | 87 126 |
16-04-24 | 0,452 | -4,03% | 167 856 |
15-04-24 | 0,471 | -8,08% | 166 327 |
uitgestelde koers Nasdaq, 19 april 2024 om 15:57 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,77% | 8,66 mln. | |
-2,50% | 102 mld. | |
+2,49% | 96,07 mld. | |
-1,22% | 21,66 mld. | |
-17,20% | 20,77 mld. | |
-7,01% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-27,85% | 13,79 mld. | |
+0,25% | 13,33 mld. | |
+20,54% | 10,94 mld. |